Unanticipated Analyst Projections for IYK Over the Next Year

Analysts See Upside Potential for iShares U.S. Consumer Staples ETF

In our analysis of the ETFs within our coverage at ETF Channel, we assessed the trading prices of each holding against average analyst 12-month forward target prices. From this, we calculated the weighted average implied analyst target price for the iShares U.S. Consumer Staples ETF (Symbol: IYK), which comes in at $74.60 per unit.

Currently, IYK is trading around $67.96 per unit. This pricing reflects an estimated 9.78% upside potential as viewed by analysts, considering the average targets for its underlying holdings. Notable stocks contributing to this potential include CVS Health Corporation (Symbol: CVS), Tyson Foods Inc (Symbol: TSN), and Kenvue Inc (Symbol: KVUE).

For CVS, trading at $63.78 per share, the average analyst target sits at $72.32, indicating a 13.39% upside. Tyson Foods currently trades at $58.16, demonstrating an 11.75% upside potential with a target price of $65.00. Meanwhile, Kenvue shares are priced at $21.73, with analysts projecting a price target of $23.93, suggesting a 10.14% upside. A twelve-month price history chart illustrating the performance of CVS, TSN, and KVUE is shown below:

CVS, TSN, and KVUE Relative Performance Chart

Combined, CVS, TSN, and KVUE account for 6.25% of the iShares U.S. Consumer Staples ETF. Below is a summary table detailing the current analyst target prices for these stocks:

Name	Symbol	Recent Price	Avg. Analyst 12-Mo. Target	% Upside to Target
iShares U.S. Consumer Staples ETF	IYK	$67.96	$74.60	9.78%
CVS Health Corporation	CVS	$63.78	$72.32	13.39%
Tyson Foods Inc	TSN	$58.16	$65.00	11.75%
Kenvue Inc	KVUE	$21.73	$23.93	10.14%

Are the analysts’ targets justified, or are they overly optimistic regarding these stocks’ future trading prices? A substantial price target relative to a stock’s current price often signals optimism but may lead to downgrades if it reflects outdated expectations. Investors should conduct further research to navigate these insights.

10 ETFs With Most Upside To Analyst Targets »